Results 71 to 80 of about 19,922 (207)
Update on duloxetine for the management of stress urinary incontinence
, 2008 Maya Basu, Jonathan RA DuckettDepartment of Obstetrics and Gynaecology, Medway Maritime Hospital, Gillingham, Kent, UKAbstract: Duloxetine is a relatively balanced serotonin and noradrenaline reuptake inhibitor (SNRI), which is the first drug with widely
Maya Basu, Jonathan RA Duckett
core
A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine
Frontiers in Psychiatry, 2020 Duloxetine is a serotonin-norepinephrine reuptake inhibitor approved for the treatment of patients affected by major depressive disorder (MDD), generalized anxiety disorder (GAD), neuropathic pain (NP), fibromyalgia (FMS), and stress incontinence urinary
Daniela Rodrigues-Amorim +5 more
doaj +1 more source
Headache: The Journal of Head and Face Pain, EarlyView.Abstract Objective The objective of this study was to describe the real‐world diagnosis and treatment patterns of individuals newly diagnosed with migraine in the United States (US). Background Over 10% of adults in the US are living with migraine.
Fred Cohen +7 more
wiley +1 more source
Narcolepsy and rapid eye movement sleep
Journal of Sleep Research, Volume 34, Issue 2, April 2025.Summary Since the first description of narcolepsy at the end of the 19th Century, great progress has been made. The disease is nowadays distinguished as narcolepsy type 1 and type 2. In the 1960s, the discovery of rapid eye movement sleep at sleep onset led to improved understanding of core sleep‐related disease symptoms of the disease (excessive ...
Francesco Biscarini +4 more
wiley +1 more source
Journal of Pain Research, 2022 Zipu Jia,1 Jinyong Yu,2 Chunmei Zhao,2 Hao Ren,2 Fang Luo2 1Department of Day Surgery Center; Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of Pain Management; Beijing Tiantan Hospital, Capital ...
Jia Z, Yu J, Zhao C, Ren H, Luo F
doaj
Journal of Sleep Research, Volume 34, Issue 2, April 2025.Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont +5 more
wiley +1 more source
Predictors of duloxetine adherence and persistence in patients with fibromyalgia
, 2012 Zhanglin Cui, Yang Zhao, Diego Novick, Douglas FariesEli Lilly and Company, Indianapolis, IN, USAObjectives: Adherence to medication for the treatment of fibromyalgia (FM) is predictive of lower overall health-care costs, and thus a lower burden on both ...
Novick D, Cui Z, Faries D, Zhao Y
core
Duloxetine reduced the cardiostimulant response to MDMA.
, 2012 Duloxetine reduced the elevations in mean arterial blood pressure (a) and heart rate (b) in response to MDMA. Duloxetine also nonsignificantly lowered the MDMA-induced increase in body temperature (c). Values are expressed as mean+SEM of 16 subjects.
Marius C. Hoener (166578) +9 more
core +1 more source
The Journal of Physiology, EarlyView.Abstract figure legend A mechanistic framework linking sex‐dependent dynamical instability to proarrhythmic risk. Sex‐specific human ventricular models show that upstream modulators, including biological sex, hormones, drugs and heart disease, promote steeper APD restitution in female than male and enhance dynamical instability.
Daisuke Sato +3 more
wiley +1 more source
Duloxetine for the treatment of generalized anxiety disorder: a review
, 2008 Ahsan Y Khan, Matthew MacalusoDepartment of Psychiatry and Behavioral Sciences, University of Kansas School of Medicine-Wichita, Wichita, KS, USAAbstract: Approximately 16 million people in the United States suffer from anxiety disorders alone, while ...
Ahsan Y Khan, Matthew Macaluso
core